BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10222437)

  • 1. Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma.
    Ozaki S; Nishizaki T; Ito H; Sasaki K
    J Neurooncol; 1999 Jan; 41(2):167-74. PubMed ID: 10222437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoglu H; Atasoy MA; Başaran N; Tel E
    Neurol Med Chir (Tokyo); 2003 Jan; 43(1):12-8; discussion 19. PubMed ID: 12568317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
    Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal losses and gains in meningiomas: comparative genomic hybridization (CGH) study of the whole genome.
    Maruno M; Yoshimine T; Muhammad AK; Ninomiya H; Hayakawa T
    Neurol Res; 1998 Oct; 20(7):612-6. PubMed ID: 9785589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.
    Weber RG; Boström J; Wolter M; Baudis M; Collins VP; Reifenberger G; Lichter P
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14719-24. PubMed ID: 9405679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas.
    Espinosa AB; Mackintosh C; Maíllo A; Gutierrez L; Sousa P; Merino M; Ortiz J; de Alava E; Orfao A; Tabernero MD
    Eur J Hum Genet; 2008 Dec; 16(12):1450-8. PubMed ID: 18628790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
    Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
    Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
    Müller P; Henn W; Niedermayer I; Ketter R; Feiden W; Steudel WI; Zang KD; Steilen-Gimbel H
    Clin Cancer Res; 1999 Nov; 5(11):3569-77. PubMed ID: 10589773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
    Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
    Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel chromosomal aberrations in a recurrent malignant meningioma.
    Pelz AF; Klawunde P; Skalej M; Wieacker P; Kirches E; Schneider T; Mawrin C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):48-53. PubMed ID: 17350466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomic hybridization analysis of radiation-associated and sporadic meningiomas.
    Rienstein S; Loven D; Israeli O; Ram Z; Rappaport ZH; Barkai G; Goldman B; Aviram-Goldring A; Friedman E
    Cancer Genet Cytogenet; 2001 Dec; 131(2):135-40. PubMed ID: 11750053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal involvement secondary to -22 in human meningiomas.
    Rey JA; Bello MJ; de Campos JM; Kusak E; Moreno S
    Cancer Genet Cytogenet; 1988 Jul; 33(2):275-90. PubMed ID: 3383169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of chromosome 14 abnormalities by interphase in situ hybridization and comparative genomic hybridization in 124 meningiomas: correlation with clinical, histopathologic, and prognostic features.
    Tabernero MD; Espinosa AB; Maíllo A; Sayagués JM; Alguero Mdel C; Lumbreras E; Díaz P; Gonçalves JM; Onzain I; Merino M; Morales F; Orfao A
    Am J Clin Pathol; 2005 May; 123(5):744-51. PubMed ID: 15981814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Masked hypodiploidy in anaplastic meningiomas by duplication of the original clone found in atypical meningiomas: illustration of the evolution of genetic alterations.
    Ely EE; Guzman MA; Calvey LS; Batanian JR
    Neuropathology; 2014 Aug; 34(4):353-9. PubMed ID: 24612240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.